1Katsinelos P,Paroutoglou G,Kountouras J,Zavos C,Beltsis A,Tzovaras G.Efficacy and safety of therapeutic ERCP in patients 90 years of age and older[J].Gastrointest Endosc,2006,63:417-423.
2Gottumukkala S R.Prevention of post-ERCP pancreatitis:are there any pearls for sale[J].Gastroenterology,2004,127:348-350.
5Dickinson R J,Davies S.Post-ERCP pancreatitis and hyperamylasaemin:the role of operative and patient factors[J].Eur J Gastroenterol Hepatol,1998,10:423-428.
6Thomopoulos K C,Vagenas K,Assimakopoulos S F,Giannikoulis C,Arvaniti V,Pagoni N,et al.Endoscopic retrogade cholangiopancreatography is safe and effective method for diagnosis and treatment of biliary and pancreatic disorders in octogenarians[J].Acta Gastroenterol Belg,2007,70:199-202.
7Dickinson R J, Davies S. Post-ERCP pancratitis and hyperamylasaemin : the role of perative and patient factors [ J ]. Eur J Gastroenterol Hepatol, 1998,10:423.
8Johnson GK, Geenen JE, Johanson JF, et al. Evaluation of post-ERCP pancreatits ;potential causes noted during controlled study of differing contrast media midwest pancreaticobiliarty study grop[ J]. Gastrointest Endosc, 1997,46:217.
9Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis : a prospective, multicenter study [ J ]. Gastrointest Endosc ,2001,54:425.
10Masci E, Toil G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP:a prospective multicenter study [ J ]. Am J Gaslroenterol,2001,96 ;417.
3Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP [J]. Gastrointest Endosc ,2002,56 ( 5 ) :652-656.
4Zheng M, Bai J, Yuan B, et al. Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis [ J]. BMC Gastroenterol,2008 ,8 :6.
5Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management : an attempt at consensus [ J ]. Gastrointest Endosc, 1991,37 ( 3 ) :383-393.
6Freeman ML, DiSario JA, Nelson DB, et al . Risk factors for post- ERCP pancreatitis: a prospective, multicenter study [J]. Gastrointest Endosc,2001,54(4) :425-434.
7Masci E, Mariani A, Curioni S, et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography : a meta- analysis [ J ]. Endoscopy,2003,35 ( 10 ) : 830 -834.
8Tulassay Z. Somatostatin and the gastrointestinal tract [ J ]. Scand j Gastroenterol Suppl, 1998,228 : 115-21.
9Raty S, Sand J, Pulkkinen M, Matikainen M, et al. Post-ERCP pancreatitis: reduction by routine antibiotics [J]. J Gastreintest Surg ,2001,5 (4) :339-345.
10Ang T L, Cheng J, Khor J L, Mesenas S J, Vu K F, Wong W K.Guideline on training and credentialing in endoscopic retrograde cholangiopancreatography[J].Singapore Med J, 2011, 52:654-657.
